ASX - By Stock
|
SPL |
Re:
something has to give.....the share price is absolutely ridiculous
|
|
Biostock
|
47 |
11K |
2 |
23/07/22 |
23/07/22 |
ASX - By Stock
|
47
|
11K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
something has to give.....the share price is absolutely ridiculous
|
|
Biostock
|
47 |
11K |
0 |
23/07/22 |
23/07/22 |
ASX - By Stock
|
47
|
11K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
something has to give.....the share price is absolutely ridiculous
|
|
Biostock
|
47 |
11K |
1 |
23/07/22 |
23/07/22 |
ASX - By Stock
|
47
|
11K
|
1
|
|
ASX - By Stock
|
SPL |
intranasal treatment covid animal study
|
|
Biostock
|
1 |
509 |
0 |
23/07/22 |
23/07/22 |
ASX - By Stock
|
1
|
509
|
0
|
|
ASX - By Stock
|
SPL |
Re:
something has to give.....the share price is absolutely ridiculous
|
|
Biostock
|
47 |
11K |
3 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
47
|
11K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
The Three Amigos. Sanitised version.
|
|
Biostock
|
20 |
6.1K |
5 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
20
|
6.1K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
something has to give.....the share price is absolutely ridiculous
|
|
Biostock
|
47 |
11K |
5 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
47
|
11K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE Protects Against Omicron in Viral Challenge Model
|
|
Biostock
|
34 |
12K |
3 |
20/07/22 |
20/07/22 |
ASX - By Stock
|
34
|
12K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE Protects Against Omicron in Viral Challenge Model
|
|
Biostock
|
34 |
12K |
4 |
20/07/22 |
20/07/22 |
ASX - By Stock
|
34
|
12K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Management team
|
|
Biostock
|
9 |
2.7K |
2 |
20/07/22 |
20/07/22 |
ASX - By Stock
|
9
|
2.7K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Good to see another AZD0466 trial for indication of NHD
|
|
Biostock
|
19 |
5.4K |
3 |
18/07/22 |
18/07/22 |
ASX - By Stock
|
19
|
5.4K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Management team
|
|
Biostock
|
9 |
2.7K |
2 |
18/07/22 |
18/07/22 |
ASX - By Stock
|
9
|
2.7K
|
2
|
|
ASX - By Stock
|
SPL |
Management team
|
|
Biostock
|
9 |
2.7K |
1 |
17/07/22 |
17/07/22 |
ASX - By Stock
|
9
|
2.7K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE relaunched by LloydsPharmacy in the UK
|
|
Biostock
|
253 |
67K |
0 |
17/07/22 |
17/07/22 |
ASX - By Stock
|
253
|
67K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
In-house DEP trial prediction
|
|
Biostock
|
68 |
16K |
9 |
15/07/22 |
15/07/22 |
ASX - By Stock
|
68
|
16K
|
9
|
|
ASX - By Stock
|
SPL |
Re:
Oh dear ~ CEO Jackie Fairley
|
|
Biostock
|
13 |
4.3K |
1 |
12/07/22 |
12/07/22 |
ASX - By Stock
|
13
|
4.3K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Access to antiviral tablets but not Viraleze
|
|
Biostock
|
5 |
2.3K |
4 |
11/07/22 |
11/07/22 |
ASX - By Stock
|
5
|
2.3K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Access to antiviral tablets but not Viraleze
|
|
Biostock
|
5 |
2.3K |
5 |
10/07/22 |
10/07/22 |
ASX - By Stock
|
5
|
2.3K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Why hasn't the TGA approved Viraleze in Australia yet!!!
|
|
Biostock
|
49 |
12K |
0 |
07/07/22 |
07/07/22 |
ASX - By Stock
|
49
|
12K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Why hasn't the TGA approved Viraleze in Australia yet!!!
|
|
Biostock
|
49 |
12K |
2 |
07/07/22 |
07/07/22 |
ASX - By Stock
|
49
|
12K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
J K Fairley
|
|
Biostock
|
3 |
1.3K |
1 |
07/07/22 |
07/07/22 |
ASX - By Stock
|
3
|
1.3K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE relaunched by LloydsPharmacy in the UK
|
|
Biostock
|
253 |
67K |
2 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
253
|
67K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE relaunched by LloydsPharmacy in the UK
|
|
Biostock
|
253 |
67K |
3 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
253
|
67K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE relaunched by LloydsPharmacy in the UK
|
|
Biostock
|
253 |
67K |
6 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
253
|
67K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE relaunched by LloydsPharmacy in the UK
|
|
Biostock
|
253 |
67K |
1 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
253
|
67K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE relaunched by LloydsPharmacy in the UK
|
|
Biostock
|
253 |
67K |
8 |
05/07/22 |
05/07/22 |
ASX - By Stock
|
253
|
67K
|
8
|
|
ASX - By Stock
|
SPL |
Re:
Blood cancer clinical trials are dropping like flies
|
|
Biostock
|
4 |
1.3K |
1 |
04/07/22 |
04/07/22 |
ASX - By Stock
|
4
|
1.3K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE relaunched by LloydsPharmacy in the UK
|
|
Biostock
|
253 |
67K |
3 |
02/07/22 |
02/07/22 |
ASX - By Stock
|
253
|
67K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE relaunched by LloydsPharmacy in the UK
|
|
Biostock
|
253 |
67K |
0 |
01/07/22 |
01/07/22 |
ASX - By Stock
|
253
|
67K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Looking forward to the following leading up to AGM
|
|
Biostock
|
13 |
4.1K |
2 |
01/07/22 |
01/07/22 |
ASX - By Stock
|
13
|
4.1K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
New interview with Jackie Fairley CEO of Starpharma
|
|
Biostock
|
21 |
5.5K |
1 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
21
|
5.5K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
New interview with Jackie Fairley CEO of Starpharma
|
|
Biostock
|
21 |
5.5K |
2 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
21
|
5.5K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
An AWOL CEO
|
|
Biostock
|
3 |
1.2K |
0 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
3
|
1.2K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
For the scientists
|
|
Biostock
|
2 |
561 |
2 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
2
|
561
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Remember the time
|
|
Biostock
|
8 |
2.0K |
5 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
8
|
2.0K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
New interview with Jackie Fairley CEO of Starpharma
|
|
Biostock
|
21 |
5.5K |
3 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
21
|
5.5K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Why hasn't the TGA approved Viraleze in Australia yet!!!
|
|
Biostock
|
49 |
12K |
3 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
49
|
12K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Why hasn't the TGA approved Viraleze in Australia yet!!!
|
|
Biostock
|
49 |
12K |
2 |
28/06/22 |
28/06/22 |
ASX - By Stock
|
49
|
12K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: SPL signs expanded DEP research agreement with US Biopharma
|
|
Biostock
|
29 |
8.6K |
4 |
27/06/22 |
27/06/22 |
ASX - By Stock
|
29
|
8.6K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Its the Happy Sarge show
|
|
Biostock
|
9 |
2.4K |
7 |
25/06/22 |
25/06/22 |
ASX - By Stock
|
9
|
2.4K
|
7
|
|
ASX - By Stock
|
SPL |
Re:
Even though I have patience..........An EGM is a pi
|
|
Biostock
|
3 |
1.6K |
1 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
3
|
1.6K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Covid-19 Update Australia - TGA bring on VIRALEZE™
|
|
Biostock
|
7 |
2.2K |
0 |
22/06/22 |
22/06/22 |
ASX - By Stock
|
7
|
2.2K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
VivaGel BV sales guidance
|
|
Biostock
|
1 |
483 |
1 |
22/06/22 |
22/06/22 |
ASX - By Stock
|
1
|
483
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Patience
|
|
Biostock
|
11 |
2.7K |
0 |
22/06/22 |
22/06/22 |
ASX - By Stock
|
11
|
2.7K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Vietnam Viraleze update
|
|
Biostock
|
10 |
3.8K |
1 |
22/06/22 |
22/06/22 |
ASX - By Stock
|
10
|
3.8K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE to relaunch in the UK
|
|
Biostock
|
92 |
28K |
1 |
14/06/22 |
14/06/22 |
ASX - By Stock
|
92
|
28K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
I'm Out, so SPL should rocket higher
|
|
Biostock
|
28 |
10K |
0 |
11/06/22 |
11/06/22 |
ASX - By Stock
|
28
|
10K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Versatility of SPL7013 molecule
|
|
Biostock
|
11 |
3.9K |
0 |
09/06/22 |
09/06/22 |
ASX - By Stock
|
11
|
3.9K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Are you a pumper dumper?
|
|
Biostock
|
7 |
2.5K |
4 |
09/06/22 |
09/06/22 |
ASX - By Stock
|
7
|
2.5K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Versatility of SPL7013 molecule
|
|
Biostock
|
11 |
3.9K |
2 |
09/06/22 |
09/06/22 |
ASX - By Stock
|
11
|
3.9K
|
2
|
|